• FLUNARIZINE CHEMBL30008 FDA Approved

    Alternate Names:

    NCGC00018102-06
    Flunarizine
    1-[BIS-(4-FLUORO-PHENYL)-METHYL]-4-(3-PHENYL-ALLYL)-PIPERAZINE(FLUNARIZINE)
    4-((2E)-3-PHENYLPROP-2-ENYL)-1-[BIS(4-FLUOROPHENYL)METHYL]PIPERAZINE
    1-[BIS-(4-FLUORO-PHENYL)-METHYL]-4-((E)-3-PHENYL-ALLYL)-PIPERAZINE
    1-[BIS(4-FLUOROPHENYL)METHYL]-4-[(2E)-3-PHENYL-2-PROPENYL]PIPERAZINE
    1-[BIS-(4-FLUORO-PHENYL)-METHYL]-4-(3-PHENYL-ALLYL)-PIPERAZINE
    1-[''BIS''(4-FLUOROPHENYL)METHYL]-4-CINNAMYL-PIPERAZINE
    118378-EP2298765A1
    118378-EP2298764A1
    118378-EP2280008A2
    118378-EP2275420A1
    118378-EP2270011A1
    AB00053586-15
    FT-0630654
    ST024768
    HE237173
    DR002390
    BC204194
    AN-15108
    AK129827
    AJ-72874
    NCGC00018102-12
    NCGC00018102-10
    NCGC00018102-08
    NCGC00018102-07
    NCGC00018102-05
    NCGC00018102-04
    CCG-204617
    TOX21_110825_1
    AKOS015960783
    ZINC19360739
    DAP000142
    BDBM50017702
    TOX21_110825
    SMANXXCATUTDDT-QPJJXVBHSA-N
    MOLPORT-000-732-712
    CHEBI:138764
    CID_6365505
    SCHEMBL43441
    SCHEMBL43440
    R7PLA2DM0J
    CID941361
    NARZINE
    FLUNARAZINE
    1-[BIS(4-FLUOROPHENYL)METHYL]-4-CINNAMYLPIPERAZINE
    CAS-52468-60-7
    PIPERAZINE, 1-[BIS(4-FLUOROPHENYL)METHYL]-4-[(2E)-3-PHENYL-2-PROPENYL]-
    PIPERAZINE, 1-(BIS(4-FLUOROPHENYL)METHYL)-4-(3-PHENYL-2-PROPENYL)-
    1-[BIS(4-FLUOROPHENYL)METHYL]-4-[(E)-3-PHENYLPROP-2-ENYL]PIPERAZINE
    1-[BIS(4-FLUOROPHENYL)METHYL]-4-[(E)-CINNAMYL]PIPERAZINE
    BRD-K29582677-300-05-6
    BRD-K29582677-001-02-7
    BRD-K12184470-300-01-8
    40218-96-0
    DSSTOX_GSID_45616
    DSSTOX_RID_81005
    DSSTOX_CID_25616
    PIPERAZINE, 1-[BIS(4-FLUOROPHENYL)METHYL]-4-(3-PHENYL-2-PROPENYL)-, (E)-
    D07971
    LS-110464
    NCGC00024308-07
    NCGC00024308-06
    NCGC00024308-05
    NCGC00024308-04
    NCGC00018102-09
    (E)-1-[BIS-(P-FLUOROPHENYL)METHYL]-4-CINNAMYLPIPERAZINE
    IDI1_033811
    IDI1_000043
    DB04841
    AC-1283
    AR-1B9446
    PIPERAZINE, 1-(BIS(4-FLUOROPHENYL)METHYL)-4-(3-PHENYL-2-PROPENYL)-, (E)-
    30484-77-6 (DI-HYDROCHLORIDE)
    EINECS 254-842-0
    KST-1B4966
    HMS2089H21
    HMS1989D03
    HMS1791D03
    HMS1361D03
    C26H26F2N2
    BCBCMAP01_000120
    BPBIO1_000336
    BIO-0741
    BSPBIO_003096
    BSPBIO_001341
    BSPBIO_000304
    LOPAC0_000527
    1-[BIS(4-FLUOROPHENYL)METHYL]-4-(3-PHENYLPROP-2-EN-1-YL)PIPERAZINE
    (E)-1-(BIS(4-FLUOROPHENYL)METHYL)-4-(3-PHENYL-2-PROPENYL)PIPERAZINE
    UNII-R7PLA2DM0J
    EINECS 257-937-5
    SPECTRUM5_001570
    PRESTWICK3_000312
    PRESTWICK2_000312
    AC1Q4NMD
    APO-FLUNARIZINE CAPSULES
    AC1LIZWP
    FLUNARIZINE (INN)
    SIBELIUM (TN)
    NOVO-FLUNARIZINE
    FLUNARIZINE [INN:BAN]
    VERTIX
    ISSIUM
    FLUVERT
    FLUFENAL
    FLUNARIZINA [INN-SPANISH]
    FLUNARIZINUM [INN-LATIN]
    1-(BIS(4-FLUOROPHENYL)METHYL)-4-CINNAMYLPIPERAZINE
    ZINASEN
    FLUNARIZIN
    FLUNARIZINUM
    FLUNARIZINA
    52468-60-7
    SIBELIUM
    941361
    Sibelium Cap 5mg
    Novo-flunarizine - Cap 5mg
    Gradient
    Fluxarten
    Flugeral
    1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine
    5343-57-7
    181267

    Drug Info:

    Drug Class anticonvulsants
    Year of Approval not approved by the fda
    Drug Class vasodilator agents
    Drug Categories vasodilator agents
    Drug Categories therapeutic uses
    Drug Categories piperazines
    Drug Categories physiological effects of drugs
    Drug Categories pharmacologic actions
    Drug Categories neurotransmitter agents
    Drug Categories nervous system
    Drug Categories molecular mechanisms of pharmacological action
    Drug Categories membrane transport modulators
    Drug Categories histamine h1 antagonists
    Drug Categories histamine antagonists
    Drug Categories histamine agents
    Drug Categories heterocyclic compounds, 1-ring
    Drug Categories heterocyclic compounds
    Drug Categories cytochrome p-450 cyp2d6 substrates
    Drug Categories cytochrome p-450 cyp2c9 substrates
    Drug Categories cytochrome p-450 cyp2b6 substrates
    Drug Categories cytochrome p-450 cyp2a6 substrates
    Drug Categories cytochrome p-450 cyp1a2 substrates
    Drug Categories chemical actions and uses
    Drug Categories central nervous system depressants
    Drug Categories central nervous system agents
    Drug Categories cardiovascular agents
    Drug Categories calcium channel blockers
    Drug Categories antivertigo preparations
    Drug Categories anticonvulsants
    Drug Groups approved
    Drug Type small molecule
    FDA Approval not approved by the FDA
    Drug Class small molecule
    Drug Indications Vasodilator Agents
    Drug Indications Anticonvulsants
    (1 More Sources)